A bill recently passed by the West Virginia legislature would undo the state’s mandate for newborns to receive prophylaxis ...

There are currently no proven therapies that reduce cisplatin-induced acute kidney injury (AKI) in patients with cancer.

Panelists discuss how sulopenem etzadroxil/probenecid, approved in October 2024, functions as an oral β-lactam/β-lactamase inhibitor effective against extended-spectrum β-lactamase producers per SURE ...